Federal Government prioritizes hepatitis B and C prevention to curb liver cancer

Speaking at the 5th Africa Hepato-Pancreato-Biliary Cancer Consortium Conference in Abuja, Salako, represented by Prof. Musa Ali-Gonbe, Director of Clinical Services at the National Institute for Cancer Research and Treatment, highlighted challenges in Nigeria's cancer response, including late presentation, inadequate diagnostic services, and high treatment costs. He stated that particular attention is being given to liver cancer through vaccination, screening, diagnosis, and treatment for hepatitis B and C. The government is also integrating cancer screening into primary healthcare and strengthening referral pathways. Salako emphasized the critical need for stronger collaboration among various stakeholders, sustainable financing, and political commitment to improve cancer outcomes.

He also mentioned initiatives like the National Cancer Health Fund and the Cancer Access Partnership Programme to strengthen financial protection for patients. Dr. Folakemi Odedina, a cancer researcher at Mayo Clinic, called for developing the next generation of scientists and leaders, stressing the importance of mentorship and legacy. Prof. Abidemi Omonisi, President and Chief Executive Officer of the Nigerian Cancer Society, raised concerns about Nigeria's high hepatitis B burd